SUPRIYA LIFESCIENCE
Quarterly Results Analysis [Dec2024]
SUPRIYA LIFESCIENCE Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹186 Cr | ₹166 Cr | ₹161 Cr | ₹158 Cr | ₹140 Cr | ₹140 Cr | ₹132 Cr | ₹142 Cr |
Expenses | ₹120 Cr | ₹101 Cr | ₹98 Cr | ₹103 Cr | ₹99 Cr | ₹108 Cr | ₹88 Cr | ₹87 Cr |
Operating Income | ₹66 Cr | ₹65 Cr | ₹63 Cr | ₹56 Cr | ₹41 Cr | ₹32 Cr | ₹44 Cr | ₹55 Cr |
Other Income | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
Interest | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr |
Profit Before Tax | ₹63 Cr | ₹62 Cr | ₹60 Cr | ₹53 Cr | ₹40 Cr | ₹30 Cr | ₹43 Cr | ₹53 Cr |
Profit After Tax | ₹47 Cr | ₹46 Cr | ₹45 Cr | ₹37 Cr | ₹30 Cr | ₹24 Cr | ₹29 Cr | ₹38 Cr |
EPS | ₹5.81 | ₹5.73 | ₹5.55 | ₹4.59 | ₹3.70 | ₹2.97 | ₹3.54 | ₹4.75 |
Industry Peers & Returns | 1W | 1M | 1Y |
SUPRIYA LIFESCIENCE | -11.4% | 11% | 73.7% |
SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 4.6% | 3% |
DIVIS LABORATORIES | -4.8% | -3.2% | 40.7% |
CIPLA | -1.3% | -1.9% | -5.2% |
TORRENT PHARMACEUTICALS | 1.1% | 6.1% | 27.1% |
DR REDDYS LABORATORIES | -3.6% | -2.7% | -11.4% |
MANKIND PHARMA | -3.2% | 3% | 2% |
ZYDUS LIFESCIENCES | -3.6% | -5.2% | -14.9% |
LUPIN | -1.3% | -1.8% | 21.2% |
SUPRIYA LIFESCIENCE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 11.77 % |
Y-o-Y | 32.54 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹186 Cr | 11.77 | |
Sep2024 | ₹166 Cr | 3.41 | |
Jun2024 | ₹161 Cr | 1.55 | |
Mar2024 | ₹158 Cr | 12.93 | |
Dec2023 | ₹140 Cr | -0.01 | |
Sep2023 | ₹140 Cr | 6.12 | |
Jun2023 | ₹132 Cr | -7.20 | |
Mar2023 | ₹142 Cr | - |
SUPRIYA LIFESCIENCE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 1.91 % |
Y-o-Y | 58.97 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹66 Cr | 1.91 | |
Sep2024 | ₹65 Cr | 3.48 | |
Jun2024 | ₹63 Cr | 12.68 | |
Mar2024 | ₹56 Cr | 33.78 | |
Dec2023 | ₹41 Cr | 30.67 | |
Sep2023 | ₹32 Cr | -28.63 | |
Jun2023 | ₹44 Cr | -19.17 | |
Mar2023 | ₹55 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -8.80 % |
Y-o-Y | 19.95 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 35.53% | -8.80 | |
Sep2024 | 38.96% | 0.05 | |
Jun2024 | 38.94% | 10.97 | |
Mar2024 | 35.09% | 18.47 | |
Dec2023 | 29.62% | 30.71 | |
Sep2023 | 22.66% | -32.76 | |
Jun2023 | 33.7% | -12.90 | |
Mar2023 | 38.69% | - |
SUPRIYA LIFESCIENCE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 1.37 % |
Y-o-Y | 57.05 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹47 Cr | 1.37 | |
Sep2024 | ₹46 Cr | 3.37 | |
Jun2024 | ₹45 Cr | 20.88 | |
Mar2024 | ₹37 Cr | 23.98 | |
Dec2023 | ₹30 Cr | 24.72 | |
Sep2023 | ₹24 Cr | -16.23 | |
Jun2023 | ₹29 Cr | -25.42 | |
Mar2023 | ₹38 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -9.29 % |
Y-o-Y | 18.48 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 25.2 % | -9.29 | |
Sep2024 | 27.78 % | -0.04 | |
Jun2024 | 27.79 % | 19.01 | |
Mar2024 | 23.35 % | 9.78 | |
Dec2023 | 21.27 % | 24.75 | |
Sep2023 | 17.05 % | -21.06 | |
Jun2023 | 21.6 % | -19.61 | |
Mar2023 | 26.87 % | - |
SUPRIYA LIFESCIENCE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 1.40 % |
Y-o-Y | 57.03 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹5.81 | 1.40 | |
Sep2024 | ₹5.73 | 3.24 | |
Jun2024 | ₹5.55 | 20.92 | |
Mar2024 | ₹4.59 | 24.05 | |
Dec2023 | ₹3.7 | 24.58 | |
Sep2023 | ₹2.97 | -16.10 | |
Jun2023 | ₹3.54 | -25.47 | |
Mar2023 | ₹4.75 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD